88598286 - CELLREGEN

Information

• Trademark
• 88598286

• Source

• Serial Number

  88598286

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 40 - Treatment of materials
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 29, 2019
  5 years ago

• Transaction Date

  October 25, 2021
  3 years ago

• Status Date

  October 25, 2021
  3 years ago

• Published for Opposition Date

  January 26, 2021
  4 years ago

• Location Date

  March 23, 2021
  3 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  NEVILLE, JAMES B

• Attorney Docket Number

  6300.488

  Attorney Name

  John C. Stringham

  Law Office Assigned Location Code

  M50

• Owners

  • UNIVERSITY OF UTAH RESEARCH FOUNDATION, A UT CORP

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of The word "CellReGen" with the letters "C" "R" and "G" all capitalized, with the "R" having a gapped corner on the top left, all to the left of a square that has gapped corners on the top left and bottom right.
• GS0011: Biological preparations for others, namely, human cells and tissue for scientific and research use; Cells and biological tissue, namely, human tissue, stem cells, bone marrow, amniotic fluid and blood, for scientific research and use in cellular therapies; biological preparations for others, namely, human cells and tissue, for use in the research of treatment of degenerative diseases, wound healing, and cell therapy
• GS0051: Biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine
• GS0351: Business consulting and industry collaboration in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and product development; providing product commercialization assistance in the field of cellular therapy and regenerative medicine; commercialization services in the field of cellular therapy and regenerative medicine
• GS0401: Contract manufacturing, namely, manufacture of cellular therapies and regenerative medicines; conducting manufacturing support, namely, development of operating procedures and batch records, cell expansion, master and working cell bank production and clinical trials in the field of cellular therapy and regenerative medicine
• GS0411: Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine
• GS0421: Conducting clinical trials and research for others in the field of cellular therapy and regenerative medicine; providing medical and scientific research information in the field of clinical trials for cellular therapy and regenerative medicine; Product research and development; Product development consultation; Product research and development services for others in the field of cellular therapy and regenerative medicine; scientific development in the field of stem cells and regenerative medicine; scientific research, discovery, technology transfer, process development and clinical trials in the field of cellular therapy and regenerative medicine
• GS0441: Medical services in the field of cell-based therapies, including the use of biological cells and tissue in the delivery of cell-based therapies and regenerative medicine; Cell therapy services for the treatment of degenerative diseases, wounds, hematologic diseases, hematologic disorders and immuno-therapy; providing consultancy and information relating to these cell therapies for medical purposes; administration of cell therapies for the treatment of disorders, diseases, and injuries; medical services, namely, isolation of regenerative cells relating to cell therapy services, stem cell collection, processing, phenotypic characterization, infusion and storage for medical and scientific purposes; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; providing educational medical information about cellular therapy and regenerative medicines
• PM0001: CELL REGEN

Case File Event Statements

• 10/25/2021 - 3 years ago

  23 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 10/25/2021 - 3 years ago

  22 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 3/23/2021 - 3 years ago

  21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/26/2021 - 4 years ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/26/2021 - 4 years ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/6/2021 - 4 years ago

  18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/17/2020 - 4 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/16/2020 - 4 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/15/2020 - 4 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/15/2020 - 4 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/24/2020 - 4 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/24/2020 - 4 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/24/2020 - 4 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/4/2020 - 4 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/4/2020 - 4 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/4/2020 - 4 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/4/2019 - 5 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/4/2019 - 5 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/4/2019 - 5 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/2/2019 - 5 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 9/12/2019 - 5 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 9/11/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 9/2/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP